BIIB - BIOGEN INC.


187.06
-2.220   -1.187%

Share volume: 696,812
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.37%

PREVIOUS CLOSE
CHG
CHG%

$189.28
-2.22
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025 03-31-2026
Fiscal Quarter Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Report Date 08-01-2024 10-30-2024 02-12-2025 05-01-2025 07-31-2025 10-30-2025 02-06-2026 04-29-2026
Cash flow financing -245.200 M -6.600 M 7.900 M -23.000 M -11.700 M -130.200 M -137.000 M -43.800 M
Other financing cash flows 6.100 M 6.000 M 3.500 M -24.300 M 6.100 M -136.100 M -135.700 M -55.100 M
Cash flow 847.100 M -252.100 M 750.200 M 189.000 M 92.200 M 1.107 B -856.800 M 392.200 M
Net income 583.600 M 388.500 M 266.700 M 240.500 M 634.800 M 466.500 M -48.900 M 319.500 M
Depreciation 158.900 M 182.800 M 184.000 M 183.200 M 194.300 M 202.200 M 200.200 M 204.400 M
Changes in inventories 0.000 0.000 0.000 -62.000 M 0.000 0.000 0.000 -116.200 M
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow 466.500 M -1.181 B -18.600 M -47.300 M -57.000 M -35.100 M -1.232 B -209.500 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other -2.600 M -1.100 M -300.000 K -200.000 K -30.400 M 50.800 M 22.700 M -200.000 K
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 33.500 M 49.400 M 39.300 M 37.100 M 26.600 M 46.200 M 43.900 M 51.200 M
Cash Change 847.100 M -252.100 M 750.200 M 189.000 M 92.200 M 1.107 B -856.800 M 392.200 M